133 related articles for article (PubMed ID: 2529980)
1. [Analogs of gonadoliberin in the treatment of endometriosis and uterine myoma. Comparison of daily subcutaneous treatment and intramuscular depot therapy].
Horský J; Cerný M; Dvorák P; Lepová B; Zizkovský V; Vondrácek J
Cesk Gynekol; 1989 Aug; 54(7):486-95. PubMed ID: 2529980
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of an LH-RH agonist in the management of uterine leiomyomas: a study of 17 cases.
George M; Lhomme C; Lefort J; Gras C; Comaru-Schally AM; Schally AV
Int J Fertil; 1989; 34(1):19-24. PubMed ID: 2565299
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of uterine myoma with long-acting gonadotropin-releasing hormone agonist prior to myomectomy.
Liu CH; Lin YS; Lin CC; Tzeng CC; Chou CY
J Formos Med Assoc; 1993 Jun; 92(6):536-9. PubMed ID: 8106041
[TBL] [Abstract][Full Text] [Related]
4. The application of GnRH analogues in the treatment of uterine myomas in perimenopausal women.
Dragojević-Dikić S; Vućić M
Ginekol Pol; 1998 Jan; 69(1):28-33. PubMed ID: 9553319
[TBL] [Abstract][Full Text] [Related]
5. Monthly administration of the LH-RH analogue decapeptyl for long-term treatment of ovarian dysfunctions and estrogen-dependent disorders.
Geisthoevel F; Hils K; Wieacker P; Breckwoldt M; Schultheiss H
Int J Fertil; 1989; 34(4):262-70. PubMed ID: 2570764
[TBL] [Abstract][Full Text] [Related]
6. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas.
Golan A; Bukovsky I; Schneider D; Ron-el R; Herman A; Caspi E
Fertil Steril; 1989 Sep; 52(3):406-11. PubMed ID: 2528476
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
Zorn JR; Tanger C; Roger M; Grenier J; Comaru-Schally AM; Schally AV
Int J Fertil; 1986; 31(1):11-3, 16-27. PubMed ID: 2908272
[TBL] [Abstract][Full Text] [Related]
9. Pre-surgical treatment of uterine myomas with LH-RH agonists.
D'Addato F; Repinto A; Andreoli C
Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
[TBL] [Abstract][Full Text] [Related]
10. Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma.
Waibel-Treber S; Minne HW; Scharla SH; Bremen T; Ziegler R; Leyendecker G
Hum Reprod; 1989 May; 4(4):384-8. PubMed ID: 2526152
[TBL] [Abstract][Full Text] [Related]
11. [Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
Pathol Biol (Paris); 1990 Nov; 38(9):941-3. PubMed ID: 2148976
[TBL] [Abstract][Full Text] [Related]
12. GnRH analogs in treating uterine leiomyomata and endometriosis.
Szczurowicz A; Wydra D
Clin Exp Obstet Gynecol; 1996; 23(4):214-9. PubMed ID: 9001782
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
[TBL] [Abstract][Full Text] [Related]
14. [Triptorelin therapy in uterine leiomyomatosis. Study of 18 cases].
Zarcone R; Monarca M; Vullo G; Bellini P; Carfora E; Tartaglia E
Minerva Ginecol; 1998; 50(1-2):39-42. PubMed ID: 9577154
[TBL] [Abstract][Full Text] [Related]
15. Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study.
Gerhard I; Schindler AE; Bühler K; Winkler U; Meinen K; Mancarella D; Hoffmann G; Schüssler B; Kimmig R; Kranzfelder D
Clin Ther; 1992; 14 Suppl A():3-16. PubMed ID: 1535021
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
Kang JL; Wang XX; Nie ML; Huang XH
Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
Stolz W; Pfützenreuter N
Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
20. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
Lindsay PC; Shaw RW; Bennink HJ; Kicovic P
Fertil Steril; 1996 Feb; 65(2):342-8. PubMed ID: 8566259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
